An early focus on access is essential for long-term success because it can improve competitive positioning in indications with other treatment options. Phased commercialization approaches offer a variety of benefits because they allow strategies to be refined, expanded, or eliminated based on real-world evidence of success. Instead, drug developers can apply their deep expertise in drug development to transform their drug commercialization strategies. For years, the ingrained conventional wisdom that the overall success of a new drug launch is determined in the six months following approval has shaped stakeholders’ expectations. These tools provide real-time and real-world insights into field activity, customer-level sales, market access, and claims data, allowing you to see which HCPs are prescribing and which patients are filling prescriptions.

Source: New York Times September 06, 2023 12:02 UTC